Journey Medical (DERM)
(Delayed Data from NSDQ)
$6.99 USD
-0.36 (-4.90%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $6.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Journey Medical Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
DERM 6.99 -0.36(-4.90%)
Will DERM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DERM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DERM
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
DERM: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
Other News for DERM
DERM: B. Riley Securities Raises Price Target for Journey Medical | DERM Stock News
New Price Target for Journey Medical (DERM)
Journey Medical price target raised by $3 at B. Riley, here's why
DERM Expands Coverage for Rosacea Treatment Emrosi | DERM Stock News